ADC Therapeutics (ADCT) Earnings Date, Estimates & Call Transcripts → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free adct Stock Alerts $4.45 -0.45 (-9.18%) (As of 05/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMay. 6ConfirmedActual EPS (May. 6) -$0.56 Consensus EPS (May. 6) -$0.56 Read Call TranscriptListen to Call Get ADC Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for ADCT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueADCT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ADCT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Gold Gate CapitalUrgent Alert: Is the U.S. Implementing a Digital Dollar?Our exclusive guide, "Exploring the Future of the U.S. Dollar in a Digital World," is your essential resource in navigating this uncertain terrain. Inside, you'll find expert insights, strategies, and actionable steps to shield your wealth from the impending digital dollar storm.Limited time offer! Claim your guide today and stay ahead of the digital dollar revolution. ADC Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.56)($0.56)($0.56)Q2 20241($0.58)($0.58)($0.58)Q3 20241($0.59)($0.59)($0.59)Q4 20241($0.60)($0.60)($0.60)FY 20244($2.33)($2.33)($2.33)ADCT Earnings Date and InformationADC Therapeutics last posted its earnings results on May 6th, 2024. The reported ($0.56) earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of ($0.56). ADC Therapeutics has generated ($2.93) earnings per share over the last year (($2.93) diluted earnings per share). Earnings for ADC Therapeutics are expected to grow in the coming year, from ($2.20) to ($1.59) per share. Read More ADC Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript5/6/2024Q1 2024($0.56)($0.56)-($0.56)-- 3/13/2024Q4 2023($0.47)($1.03)($0.56)($1.03)$16.58 million$16.79 million11/7/2023Q3 2023($0.61)($0.58)+$0.03($0.58)$14.57 million$14.49 million8/8/2023Q2 2023($0.44)($0.58)($0.14)($0.58)$34.77 million$19.28 million5/9/2023Q1 2023($0.80)($0.74)+$0.06($0.74)$20.10 million$18.99 million2/28/2023Q4 2022($0.49)($0.30)+$0.19($0.30)$75.53 million$69.80 million Get the Latest News and Ratings for ADCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ADC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($0.51)($0.65)($0.14)($0.65)$55.61 million$76.32 million8/9/2022Q2 2022($0.96)($0.84)+$0.12($0.84)$20.18 million$17.29 million 5/9/2022Q1 2022($0.76)($0.22)+$0.54($0.22)$29.90 million$46.50 million 3/3/2022Q4 2021($0.87)($0.45)+$0.42($0.45)$16.40 million$17.01 million 11/2/2021Q3 2021($0.92)($0.93)($0.01)($0.93)$7.74 million$13.15 million 8/2/2021Q2 2021($0.86)($0.96)($0.10)($0.95)$5.70 million$3.76 million ADC Therapeutics Earnings - Frequently Asked Questions When did ADC Therapeutics announce their last quarterly earnings? ADC Therapeutics (NYSE:ADCT) last announced its quarterly earning data on Monday, May 6, 2024. Learn more on ADCT's earnings history. Did ADC Therapeutics beat their earnings estimates last quarter? In the previous quarter, ADC Therapeutics (NYSE:ADCT) reported ($0.56) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.56). Learn more on analysts' earnings estimate vs. ADCT's actual earnings. How can I listen to ADC Therapeutics's earnings conference call? The conference call for ADC Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read ADC Therapeutics's conference call transcript? The conference call transcript for ADC Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does ADC Therapeutics generate each year? ADC Therapeutics (NYSE:ADCT) has a recorded annual revenue of $69.56 million. How much profit does ADC Therapeutics generate each year? ADC Therapeutics (NYSE:ADCT) has a recorded net income of -$240.05 million. ADCT has generated -$2.93 earnings per share over the last four quarters. What is ADC Therapeutics's EPS forecast for next year? ADC Therapeutics's earnings are expected to grow from ($2.20) per share to ($1.59) per share in the next year. More Earnings Resources from MarketBeat Related Companies: NATR Earnings Results HROW Earnings Results ESPR Earnings Results RVNC Earnings Results AMRN Earnings Results LXRX Earnings Results HRTX Earnings Results MREO Earnings Results MRSN Earnings Results BMEA Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Tech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat This page (NYSE:ADCT) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyDollar CancelledLear CapitalUrgent Alert: Is the U.S. Implementing a Digital Dollar?Gold Gate CapitalDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADC Therapeutics SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
